The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Validation study of a prognostic classification system in patients with metastatic colorectal cancer who received irinotecan-based second-line chemotherapy.
Kentaro Yamazaki
No relevant relationships to disclose
Yoichi Naito
No relevant relationships to disclose
Satoshi Yuki
No relevant relationships to disclose
Yasuyuki Kawamoto
No relevant relationships to disclose
Hirofumi Yasui
No relevant relationships to disclose
Toshimi Takano
No relevant relationships to disclose
Yoshito Komatsu
No relevant relationships to disclose
Kei Muro
No relevant relationships to disclose
Kohei Shitara
No relevant relationships to disclose